Partner
Mike Morin, a nationally recognized first-chair litigator, represents clients across industries in high-stakes IP trials and appeals. He serves as Global Chair of Latham & Watkins’ Intellectual Property Litigation Practice. He previously served as Global Vice Chair of the Litigation & Trial Department and Global Co-Chair of the Healthcare & Life Sciences Industry Group.
Mike represents leading companies — from start-ups to global leaders — in their most critical intellectual property matters, including multi-billion dollar cases involving many of the world’s best-selling drugs, medical devices, consumer products, and software products. He has led some of the highest-profile patent cases in the country, particularly in the life sciences arena.
From the start of any engagement, Mike focuses on understanding a client’s business and goals — both for a specific litigation and as part of a long-term strategy. He develops early game plans and then leads teams to execute on those plans in trial, arbitration, or on appeal. He has developed an impressive track record of wins, and a roster of clients that he has successfully served for decades.
Complementing his trial and appellate work, Mike advises clients on their IP portfolios and strategies, assists with licensing and transactional issues, and counsels clients on legal positions, responsibilities, and risk management.
Mike is widely recognized as a preeminent trial lawyer.
Mike also devotes considerable time to pro bono activities, representing disabled veterans in civil matters and indigent defendants in criminal cases.
Mike is a faculty member of the Trial Advocacy College at the University of Virginia and led the Working Group on parallel district court and PTO proceedings for the Sedona Conference.
Mike’s representative experience includes serving as lead counsel for:
Co-author, “Commentary on Patent Litigation Best Practices: Parallel USPTO Proceedings Chapter (“Stage Two”),” The Sedona Conference Working Group Series (July 2017)
A Latham Complex Commercial Litigation team secured a summary judgment victory on behalf of AbbVie, Inc., eliminating all claims brought under the Illinois Genetic Information Privacy Act.
Partner Mike Morin, Global Chair of the Intellectual Property Litigation Practice, was named a 2025 Law360 Intellectual Property MVP for securing two jury trial victories in the past 18 months for Sarepta Therapeutics and Abbott Laboratories in major patent disputes involving their signature products.
The most of any law firm, the honorees were recognized for their work on market-leading transactions and high-stakes litigation and trial victories.